Josee
Josee Bordeleau, Laval CA
Patent application number | Description | Published |
---|---|---|
20110177030 | Hepatitis C Inhibitor Compounds - Compounds of formula (I): | 07-21-2011 |
20120034187 | Hepatitis C Inhibitor Compounds - Compounds of formula (I): | 02-09-2012 |
20120269769 | Hepatitis C Inhibitor Compounds - Compounds of formula (I): | 10-25-2012 |
Josee Chalut, Bartlett, TN US
Patent application number | Description | Published |
---|---|---|
20150329387 | SYSTEMS AND METHODS FOR GENERATING HALOAMINES AND APPLICATION THEREOF IN OIL AND GAS OPERATIONS - The present invention relates to systems and methods for the on-site generation (for example at oil well drilling operations, oil well hydraulic fracturing operations, makeup water pipeline transportation systems, and oil and gas refining operations) of haloamine chemistry such as chloramines and/or bromamines. The invention also relates to the application of the generated haloamines to control microorganisms such as bacteria as well their harmful byproducts such as hydrogen sulfide and other undesired substances found in oil and gas industries. | 11-19-2015 |
Josee Dostie, Montreal CA
Patent application number | Description | Published |
---|---|---|
20100130373 | MAPPING OF GENOMIC INTERACTIONS - The present invention relates to genomic analysis. In particular, the present invention provides methods and compositions for mapping genomic interactions. | 05-27-2010 |
Josee Drillet, Rozerieulles FR
Patent application number | Description | Published |
---|---|---|
20100300585 | LOW-DENSITY STEEL HAVING GOOD DRAWABILITY - The invention relates to a hot-rolled ferritic steel sheet, the composition of the steel of which comprises, the contents being expressed by weight: 0.001≦C≦0.15%, Mn≦1%, Si≦1.5%, 6%≦Al≦10%, 0.020%≦Ti≦0.5%, S≦0.050%, P≦0.1%, and, optionally, one or more elements chosen from: Cr≦1%, Mo≦1%, Ni≦1%, Nb≦0.1%, V≦0.2%, B≦0.010%, the balance of the composition consisting of iron and inevitable impurities resulting from the smelting, the average ferrite grain size d | 12-02-2010 |
Josee Morissette, Eden Prairie, MN US
Patent application number | Description | Published |
---|---|---|
20120290976 | NETWORK DISTRIBUTION OF ANATOMICAL MODELS - Techniques for presenting a three-dimensional (3D) anatomical representation of an anatomical structure are described. 3D models of various anatomical structures may be stored as prepackaged anatomical data. A user device, e.g., a networked workstation, may receive the prepackaged anatomical data from a networked computing device, e.g., a server, and present at least a portion of a 3D model as a 3D anatomical representation. The user device may also present a menu with the 3D anatomical representation that allows the user to manipulate the 3D anatomical representation and measure various aspects of the 3D anatomical representation. In some examples, the user device may also present a representation of a medical device in conjunction with the 3D anatomical representation. | 11-15-2012 |
Josee Roy, Germantown TN
Patent application number | Description | Published |
---|---|---|
20150320795 | COMPOSITIONS AND METHODS COMPRISING POLYETHYLENE GLYCOL AND MAGNESIUM FOR TREATMENT OF NEURONAL INJURY - The disclosure provides compositions, methods and kits for treatment of neuronal injury. In one embodiment, the composition comprises polyethylene glycol (PEG), and magnesium in one composition. In another embodiment, the composition comprises PEG, and magnesium, where the PEG is in separate composition and the magnesium is in a separate composition. In yet another embodiment, the PEG and/or the magnesium may be administered to treat spinal cord injury. | 11-12-2015 |
Josee Roy, Germantown, TN US
Patent application number | Description | Published |
---|---|---|
20130345314 | Compositions and methods for treating a damaged cardiovascular element - In the present invention, the applicants describe methods and compositions of treating damaged cardiovascular elements and cardiovascular conditions including hypotension, atherosclerotic lesions, vulnerable plaque, and acute myocardial infarct. The applicants demonstrate the ability of a biomembrane sealing agent to accumulate on the walls of damaged blood vessels and help improving mean arterial pressure following tissue injury. The applicants describe the use of formulations comprising at least one biomembrane sealing agent and one bioactive agent for prophylactic treatment such as they could be administered concurrently to an invasive therapeutic intervention or after the insult (i.e. post-injury or post-surgery). Alternatively, these methods and compositions could be used to reduce the severity of cardiovascular diseases after onset. | 12-26-2013 |
20150104439 | PHARMACEUTICAL REMOVAL OF NEURONAL EXTENSIONS FROM A DEGENERATING DISC - The invention provides a method for alleviating discogenic pain by administering a therapeutic agent that disrupts neuronal and/or vascular elements in the disc, which is typically a degenerated disc. Disruption of neuronal elements in the disk includes destroying nerve endings without substantially affecting the central body of the nerve, suppressing activation of the nerve endings, and inhibiting the growth of nerve endings into the disk. Disruption of vascular elements includes causing the vascular extensions to retract from the disk, or suppressing the formation of such extensions. The therapeutic agent may be administered locally via an interbody pump, a bolus or a depot, or may be administered systemically. | 04-16-2015 |